PUBLIC COMPANY
saveStanford University
updated 5mo ago
Leland Stanford Junior University, commonly referred to as Stanford University, is a private research university in Stanford, California, United States. It was founded in 1885 by railroad magnate Leland Stanford and his wife, Jane, in memory of their only child, Leland Jr.
community read0 votes
🐶 often sniffed alongside
top 8- tagMicrobiome2 co-mentions · 2 sources
- tagOncology2 co-mentions · 2 sources
- tagEndocrinology & Metabolism2 co-mentions · 1 sources
- tagHematology1 co-mentions · 1 sources
- tagWomen's Health1 co-mentions · 1 sources
- tagNephrology1 co-mentions · 1 sources
- tagImmunology1 co-mentions · 1 sources
- tagPulmonology1 co-mentions · 1 sources
pipeline
1
marketed
0
phase 3
0
catalysts ytd
48
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Phase 1
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- N/AHealth Enhanced Artery Risk Tracking With Widespread Implementation and Screening Effort in ASCVD (HEARTWISE-ASCVD)
- phase2Adjuvant ctDNA-Adapted Personalized Treatment in Early Stage NSCLC (ADAPT-E)
- N/AFall Risk Assessment and Speech Intelligibility Enhancement Using In-ear Device
- phase2REGULUS: MRI-guided Adaptive SABR for Liver Cancers
- N/AUsing Continuous Glucose Monitoring to Quantify the Effects of NOURISH's Culturally Modified Meals on Asian Americans With Type 2 Diabetes
- N/AAbdominal Scar Improvement in Microsurgical Breast Reconstruction
- phase2Adjuvant ctDNA-Adapted Treatment With Zipalertinib in Early-Stage Atypical EGFR-Mutant NSCLC
- N/AEmpowering Monterey Bay Residents for Activated, Collaborative, and Equitable Care
🐶 Hiring Signal
News
- AriBio’s oral Alzheimer’s drug meets monotherapy goal in phase 3 as Fosun weighs licensing optionAriBio’s erectile dysfunction med-turned Alzheimer’s disease candidate mirodenafil has delivered some mixed results from a global phase 3 trial. Fosun Pharma has an option to in-license the PDE5 in…fiercebiotech · 3d ago
- Opinion: Resident physicians may lose some of their most important work hour protections“It is important to create barriers between high intensity shifts with physical, intellectual, and emotional burden to avoid burnout” in residents, writes Arifeen Rahman.stat · 1mo ago
- Saudi Arabia takes actionable steps to build its biotech sector after 46 agreements in RiyadhRiyadh’s biotech summit closed with 46 agreements. Its chairman explains how Saudi Arabia plans to turn them into working programs.fiercebiotech · 1mo ago
- The Nobel boys club (again)All six Nobel awardees in physiology or medicine, physics, and chemistry this year were men. Women make up 4% of laureates since the award’s inception.stat · 1mo ago
- STAT+: Nobel-winning optogenetics research has led to experimental treatments for blindness and Alzheimer’sOptogenetics is now the foundational way through which we are able to understand how the brain worksstat · 1mo ago
- Could we one day vaccinate against every cancer?What science says so far about which cancers can be beat by vaccines — and which will require more creative approaches.stat · 1mo ago
- 2026 Nobel Prize in Medicine awarded for brain research tool called optogeneticsKarl Deisseroth, Peter Hegemann, and Georg Nagel are the joint recipients of the 2026 Nobel Prize in Physiology or Medicine “for their discoveries concerning light-gated ion channels and optogeneti…stat · 1mo ago
- Trio of scientists who developed neuron light switches win Nobel Prize in Physiology or MedicineThe 2026 Nobel Prize in Physiology or Medicine has been awarded to three scientists who forged a new neuroscience technique that uses light to precisely flip chosen neurons on and off.fiercebiotech · 1mo ago
- ‘We’ve been taking our time’: Buzzy AI biotech Xaira reveals antibody platform, first taste of pipelineWhen Xaira Therapeutics first debuted in 2024 with a gobsmacking $1 billion in funding, a natural expectation would have been for a flurry of further activity to follow. Instead, the buzzy AI biote…fiercebiotech · 1mo ago
- Opinion: Claude analyzed my genome in 30 minutes. Now we need standards for the resultsIn 2009, analyzing Euan Ashley’s whole genome took 30 people and almost a year. In 2026, he writes, Claude did it in 30 minutes for about $5.stat · 1mo ago
comments(0)
5-min edit window · permanent after that